Cilostazol and Low Dose of Methotrexate in Rheumatoid Arthritis
Status:
Not yet recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
This study aims at evaluating the therapeutic effects of Cilostazol as adjuvant therapies to
low dose of Methotrexate in patients with Rheumatoid Arthritis and to evaluate their impact
on Cyclic adenosine monophosphate(CAMP), Heme Oxygenase-1(HO-1).